Decellularized Liver Matrix-Modified Cryogel Scaffolds as Potential Hepatocyte Carriers in Bioartificial Liver Support Systems and Implantable Liver Constructs

• Published in: ACS applied materials & interfaces Vol. 10; no. 1; pp. 114 - 126
• Main Authors: Damania, Apeksha, Kumar, Anupam, Teotia, Arun K, Kimura, Haruna, Kamihira, Masamichi, Ijima, Hiroyuki, Sarin, Shiv Kumar, Kumar, Ashok
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 10.01.2018
• Subjects: Cryogels; Extracellular Matrix; Hepatocytes; Humans; Liver; Liver, Artificial; Tissue Engineering; Tissue Scaffolds; implantable liver construct; liver failure; decellularized liver; bioartificial liver; regeneration; cryogel
• ISSN: 1944-8244; 1944-8252
• DOI: 10.1021/acsami.7b13727

Recent progress in the use of decellularized organ scaffolds as regenerative matrices for tissue engineering holds great promise in addressing the issue of donor organ shortage. Decellularization preserves the mechanical integrity, composition, and microvasculature critical for zonation of hepatocytes in the liver. Earlier studies have reported the possibility of repopulating decellularized matrices with hepatic cell lines or stem cells to improve liver regeneration. In this work, we study the versatility of the decellularized liver matrix as a substrate coating of three-dimensional cryogel scaffolds. The coated cryogels were analyzed for their ability to maintain hepatic cell growth and functionality in vitro, which was found to be significantly better than the uncoated cryogel scaffolds. The decellularized liver matrix-coated cryogel scaffolds were evaluated for their potential application as a cell-loaded bioreactor for bioartificial liver support and as an implantable liver construct. Extracorporeal connection of the coated cryogel bioreactor to a liver failure model showed improvement in liver function parameters. Additionally, offline clinical evaluation of the bioreactor using patient-derived liver failure plasma showed its efficacy in improving liver failure conditions by approximately 30–60%. Furthermore, implantation of the decellularized matrix-coated cryogel showed complete integration with the native tissue as confirmed by hematoxylin and eosin staining of tissue sections. HepG2 cells and primary human hepatocytes seeded in the coated cryogel scaffolds implanted in the liver failure model maintained functionality in terms of albumin synthesis and cytochrome P450 activity post 2 weeks of implantation. In addition, a 20–60% improvement in liver function parameters was observed post implantation. These results, put together, suggest a possibility of using the decellularized matrix-coated cryogel scaffolds for liver tissue engineering applications.